Led · Grant · Jun 2026

Zymofix develops and operates Zyft, a proprietary solid-state fermentation platform that cultivates microorganisms on thermally processed agricultural sidestreams which remain part of the delivered formulation. The company is partnering with Ghent University on MicroFix, a three-year, €3.2 million research collaboration led by Prof. Tina Kyndt to build a scientific framework linking production conditions to microbial physiology, functional traits, and crop responses. Zymofix secured a €1.9 million VLAIO grant to fund its portion of that research, which will involve microbiology, plant science and modelling work. The project aims to make microbial agricultural products more predictable and reliable, strengthen regional microbial biotechnology expertise, and support creation of high-skilled R&D positions. The company also positions its approach as supporting circular bioeconomy goals through valorisation of agricultural sidestreams.

Participated · Grant · Jun 2026

Astracite is building carbon-negative battery anode materials that convert captured CO2 and silicon into high-performance graphite aimed at increasing lithium-ion battery energy density and reducing cost and supply-chain dependence. The team participated in Carbon13’s programme, which helped them secure investor introductions and raise an oversubscribed €750k pre-seed round. They also received €380k in funding from the Flemish Innovation Agency to support development. Coverage notes the company secured investor backing before having a prototype. The newly raised capital is intended to accelerate development of Astracite’s green graphite battery technology. The articles do not report revenue, users, or other operating metrics.

Led · Grant · May 2026

MRM Health develops microbiome-based biotherapeutic products using its proprietary CORAL® platform to assemble and produce disease-specific microbial consortia. The company is advancing its lead program MH002 into clinical development for ulcerative colitis and the rare condition pouchitis, while running preclinical programs in other inflammatory indications and immuno-oncology. MRM Health recently completed a €55 million Series B in September 2025 led by Biocodex with participation from ATHOS, BNP Paribas Fortis Private Equity and existing investors SFPIM, AvH, OMX Venture, QBic and VIB. The €2.6 million VLAIO grant will fund a three-year collaborative research program with Belgian academic partners to generate mechanistic and clinical microbiome data and accelerate LBP candidate development toward clinical proof-of-concept. The company is headquartered in Ghent, Belgium and reports products in clinical stages.

Led · Grant · May 2026

Spectricity focuses on developing next-generation multispectral imaging technologies and associated applications. The company has been awarded a €3 million grant from Vlaio to support its R&D efforts. The funding is designated to accelerate development of its multispectral imaging capabilities and application workstreams. The article does not provide details on revenue, users, founding year, or location. No additional operational or financial metrics were included in the report.

Participated · Seed · Mar 2026

Vertical Compute is a Belgian semiconductor startup engineering chiplets in which vertical memory stacks are integrated directly on top of compute logic during 300 mm wafer fabrication. This 3D architecture restructures on-chip data flow and addresses the longstanding “memory wall,” cutting latency and energy use compared with traditional 2D memory layouts. The company has already produced its first test chip demonstrating the concept. With a headcount of 25, Vertical Compute now plans to shift from validation to the commercial rollout of its chiplets for emerging AI platforms. Financially, the startup has secured €57 million to date, including a €20 million round in 2022 and the latest €37 million raise. No revenue figures have been disclosed, but the fresh capital provides runway for scaling manufacturing and bringing its products to market.